☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Accord BioPharma
Accord BioPharma Reports US FDA’s Acceptance of BLA for DMB-3115 (Biosimilar, Stelara)
January 4, 2024
Accord BioPharma Reports the US FDA Acceptance of BLA for HLX02, a Proposed Trastuzumab Biosimilar for Gastric Cancer and Other In...
April 5, 2023
Load more...
Back to Home
